Searched for
PHARMACEUTICAL PRICING
Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annuallyStarting November 9, consumers in India will benefit from significantly reduced prices on 137 anti-cancer drugs. The government has capped ...- These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analystsIn the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attent...
- Sai Life Sciences shares rally 9% after Q2 results; net profit rises 17%, revenue up 23%Sai Life Sciences shares jumped nearly 9% to a fresh 52-week high after strong second-quarter results. Revenue rose 23%, while net profit i...
- AI selloff drags Nikkei lower despite broad-based market gainsJapan's Nikkei 225 fell 0.5% on Thursday as losses in AI and semiconductor stocks offset gains across the broader market. Concerns over a p...
- Bombay Coated & Special Steels shares to list today; GMP points to 10% listing premiumBombay Coated & Special Steels is set to list on November 5, 2026, with a 10% grey market premium following 63.89 times IPO subscription. T...
- NPPA updates list of reduced MRP of 1,085 anti-cancer drugsThe National Pharmaceutical Pricing Authority updated the maximum retail price for 1,085 anti-cancer medicines. This revision follows a pre...
- Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brok...
- Stop the price scam in our hospitalsA recent investigation in Maharashtra has shed light on concerning price hikes for medical supplies charged to patients. Items such as IV i...
- European shares fall as tech stocks slide, Middle East tensions weighEuropean shares declined as technology stocks led losses amid concerns over AI valuations and escalating US-Iran tensions. Rising oil price...
- Emcure Pharma shares jump 7% after Q2 profit rises 29% YoY to Rs 325 croreEmcure Pharmaceuticals shares rose up to 7.3% after the company reported a 29.3% year-on-year increase in Q2 FY27 profit to Rs 325.1 crore....
- Jubilant Pharmova plans to raise Rs 800 crore via maiden bond issueJubilant Pharmova has announced plans to secure ₹800 crore via its first bond issuance within the local market, featuring ₹400 crore as the...
- High Court restrains NPPA from action against AstraZenecaThe Delhi High Court has issued a temporary restraining order against the NPPA's actions toward AstraZeneca Pharma. This order remains in e...
- Mold-Tek Packaging shares surge 17% as Q2 FY 27 profit jumps 35% YoY to Rs 21 croreMold-Tek Packaging shares surged nearly 17% after the company reported a 35.5% YoY rise in Q2 FY27 net profit and 30.5% revenue growth. Str...
- Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosyst...
- Sun Pharma Q2 Results: Profit falls 36% YoY to Rs 1,989 crore on exceptional chargesSun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported...
- Sun Pharma books Rs 346 crore Organon deal costs in Q2; profit falls 36%Sun Pharmaceutical Industries experienced a significant decline in net profit during the September quarter of FY27. The company incurred ac...
- NPPA list brings little relief: No price cut for 25% cancer drugsNearly one in four cancer drug packs in the NPPA’s revised price list will see no reduction in MRP, even as the overall average cut across ...
- India's pharma exports rise 4.9% to USD 16.14 bn in H1; shipments to Europe up nearly 10%: PharmexcilIndia's pharmaceutical exports increased nearly 5 percent, reaching USD 16.13 billion in the first half of the fiscal year. Growth was driv...
- Cancer drug price cuts leave costly brands untouchedPrices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices ...
- DRL says cap on trade margins a positive, posts 36% dip in Q2 PATIn the second quarter of FY2027, Dr. Reddy's Labs experienced a downturn in both revenue and profit. However, the company supports new trad...
Load More
